Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing outcomes in rheumatoid arthritis.

Ralph E Small1, Arthur Schuna

  • 1School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.

Journal of the American Pharmacists Association : Japha
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A telepharmacy intervention to improve inhaler adherence in veterans with chronic obstructive pulmonary disease.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2013
Same author

Pharmacists' knowledge and attitudes toward herbal medicine. 2000.

The Annals of pharmacotherapy·2007
Same author

Uses and limitations of bone mineral density measurements in the management of osteoporosis.

MedGenMed : Medscape general medicine·2005
Same author

Clinical use of methadone.

Journal of pain & palliative care pharmacotherapy·2003
Same author

Smoking cessation: pharmacists helping patients kick the habit.

Journal of the American Pharmacists Association : JAPhA·2003
Same author

Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice.

Pharmacotherapy·2002
Same journal

Healthcare cost savings through hospital pharmacist-collaborative care in heart failure: A microsimulation study.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Assessment of comprehensive medication management incorporating a patient-completed medical and medication history form in community practice.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Characterizing how community pharmacy teams engage with social drivers of health (SDOH) during routine workflow: A report from the medication safety research network of Indiana (Rx-SafeNet).

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Geographic disparities in board-certified ambulatory care pharmacists in Appalachia.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Development of consensus criteria for problematic medications in active duty service members.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Barriers and facilitators to pharmacy-based methadone dosing and dispensing: Semi-structured interviews with pharmacists.

Journal of the American Pharmacists Association : JAPhA·2026
See all related articles

Rheumatoid arthritis is a chronic inflammatory disease causing joint damage. Early treatment with disease-modifying antirheumatic drugs (DMARDs) and advanced therapies like biologics is crucial for managing pain and controlling disease progression.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease.
  • RA leads to progressive joint destruction, deformity, disability, and reduced lifespan.
  • Effective pain management is essential for patient care in RA.

Framework:

  • Early initiation of disease-modifying antirheumatic drugs (DMARDs) is key to controlling synovitis and disease progression.
  • Short-term opioid analgesics can be considered for severe arthritis pain.
  • Biological therapies targeting specific cytokines represent significant therapeutic advances.

Implementation:

  • DMARDs should be started early in the course of rheumatoid arthritis.
  • Opioid analgesics offer short-term relief for severe pain.

Related Experiment Videos

  • Biologic agents provide targeted treatment options for RA.

    • Implications:

    • Prompt RA treatment can prevent irreversible joint damage and disability.
    • Comprehensive pain management strategies improve patient quality of life.
    • Advances in biologic therapies offer new hope for RA patients, improving long-term outcomes.